No. | Document Title | ID | Updated | Views |
---|---|---|---|---|
161 | NCI/NIH Institution | 101803 | 2022-12-02 | 255 |
162 | Investigational Drug/Device | 101800 | 2022-12-02 | 244 |
163 | Fund Account No. | 101797 | 2022-11-29 | 340 |
164 | Sponsor Protocol No. | 101796 | 2022-11-29 | 258 |
165 | Sponsor Type | 101795 | 2022-11-29 | 315 |
166 | Staff: Stop Reason | 101793 | 2022-11-29 | 329 |
167 | Staff: Stop Date | 101792 | 2022-11-29 | 278 |
168 | Staff: Start Date | 101791 | 2022-11-29 | 283 |
169 | Protocol Staff Role | 70715 | 2022-11-29 | 385 |
170 | Managment Group | 101788 | 2022-11-29 | 318 |
171 | Toxicity Scheme | 24235 | 2022-11-25 | 385 |
172 | Pharmacy No. | 122680 | 2022-11-25 | 259 |
173 | IRB Committee | 101848 | 2022-11-17 | 237 |
174 | IRB: Submit Date | 101847 | 2022-11-17 | 281 |
175 | Subject MRN | 23831 | 2022-11-09 | 447 |
176 | Version Date | 99348 | 2022-10-05 | 284 |
177 | Verified By | 99349 | 2022-10-05 | 357 |
178 | Uses RC | 101825 | 2022-10-05 | 284 |
179 | Last Name | 99305 | 2022-10-05 | 256 |
180 | Race | 99312 | 2022-10-05 | 224 |
Not finding what you are looking for? Suggest a new document be created, or try adjusting your search criteria.